Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
China flag China · Delayed Price · Currency is CNY
10.38
+0.13 (1.27%)
Feb 4, 2026, 3:04 PM CST

SHE:300534 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
178.65289.65288.95369.2499.12118.19
Cash & Short-Term Investments
178.65289.65288.95369.2499.12118.19
Cash Growth
-43.42%0.24%-21.75%272.52%-16.13%128.90%
Accounts Receivable
219.07216.67223.8220.95140.44164.56
Other Receivables
16.3119.2819.519.75.535.18
Receivables
235.38235.95243.3240.65145.98169.73
Inventory
124.99115.8297.485.8755.741.55
Prepaid Expenses
-0.030.160.21.40.11
Other Current Assets
43.5435.0517.1931.576.513.52
Total Current Assets
582.55676.5647727.54308.7333.1
Property, Plant & Equipment
507.91514.24439.42333.85305.21326.76
Long-Term Investments
49.5751.3654.254.254.254.2
Goodwill
13.7213.7213.7213.7213.7218.51
Other Intangible Assets
76.4962.8162.0762.2250.7452.01
Long-Term Deferred Tax Assets
11.7311.510.128.585.776.01
Long-Term Deferred Charges
3.341.660.230.14--
Other Long-Term Assets
78.6170.51109.89117.2585.7376.07
Total Assets
1,3241,4021,3371,318824.07866.66
Accounts Payable
282.73361.08243.56209.0132.636.53
Accrued Expenses
10.7927.0823.1158.516.35.32
Short-Term Debt
--30.03--70.07
Current Portion of Long-Term Debt
-10.2----
Current Portion of Leases
-1.161.19---
Current Income Taxes Payable
10.4730.9121.117.481.782.55
Current Unearned Revenue
6.722.465.6577.2412.963.9
Other Current Liabilities
53.0766.5253.745.0814.6415.12
Total Current Liabilities
363.76519.35438.34407.3268.32103.48
Long-Term Debt
128.9795.84109.6---
Long-Term Leases
2.032.583.72---
Long-Term Unearned Revenue
47.0631.3326.4426.8922.9224.04
Long-Term Deferred Tax Liabilities
1.541.540.24-00
Other Long-Term Liabilities
23.7523.7546.8---
Total Liabilities
567.12674.39625.14434.2191.24127.53
Common Stock
303.35303.35303.35303.35303.35303.35
Additional Paid-In Capital
97.1583.8366.68324231.49231.49
Retained Earnings
291.8277.35263.68202.03185.42194.52
Comprehensive Income & Other
-2.24-2.24----
Total Common Equity
690.06662.28633.71829.38720.25729.36
Minority Interest
66.7665.6477.853.9212.599.78
Shareholders' Equity
756.82727.93711.51883.3732.84739.13
Total Liabilities & Equity
1,3241,4021,3371,318824.07866.66
Total Debt
131109.78144.54--70.07
Net Cash (Debt)
47.64179.88144.4369.2499.1248.12
Net Cash Growth
-77.01%24.56%-60.89%272.52%105.97%90.27%
Net Cash Per Share
0.160.590.481.220.330.16
Filing Date Shares Outstanding
303.35303.35303.35303.35303.35303.35
Total Common Shares Outstanding
303.35303.35303.35303.35303.35303.35
Working Capital
218.79157.15208.65320.22240.38229.62
Book Value Per Share
2.272.182.092.732.372.40
Tangible Book Value
599.84585.75557.91753.43655.78658.84
Tangible Book Value Per Share
1.981.931.842.482.162.17
Buildings
-483.38339.21338.42283.91294.39
Machinery
-198.76148.61125.1466.3565.82
Construction In Progress
-27.61105.76.0937.7635.6
Source: S&P Global Market Intelligence. Standard template. Financial Sources.